Duraclon is an antihypertensive medication that helps affected roles deal with psychological bouts and is effective in the interference of children with ADHD; however, this medication needs to be taken properly to maintain efficiency and safety.
Duraclon acts as an a2 adrenergic agonist. Generally used to treat high blood pressure by stimulating brain receptors to relax blood vessels in the body, it is also used to treat Tourette's syndrome, neuropathic pain, sleep hyperhydrosis and opioid detoxification. Duraclon can be taken with stimulants to treat ADHD. Its effects on moderate ADHD-associated oppositional and impulsive behavior are helpful in managing tics.
Duraclon is also known by the brand name Catapres and is available in a tablet, an injectable via epidural and transdermal patches. Parasympathetic activity results through central nervous system actions. A affected role's heart rate can significantly decrease with continued use of the medication. Other uses include treating migraine headaches, menopausal hot flashes, alcohol withdrawal symptoms, smoking cessation symptoms and ulcerative colitis.
Side effects can be mild, moderate or severe. Contact your healthcare professional immediately if you suffer from any of these symptoms and they become severe: dry mouth, dizziness, drowsiness, fatigability, headache, constipation, nervousness, decreased libido, upset stomach, rash and emesis. Other serious side effects include fainting, slow or rapid heartbeat, arrhythmia, swollen feet or ankles and allergic symptoms like facial and lips swelling, breathing difficulty and hives. Consult your healthcare professional if you experience any of these symptoms. Other side effects include orthostatic hypotension, xerostomia and tolerance to Duraclon. Make certain your doc knows if you experience any of these side effects.
Special precautions are to be taken with pregnant women and nursing mothers. Patients about to undergo surgery, including dental procedures, should inform their healthcare professional that they are taking this medication to avoid complications. Patients with allergies to the medication should not take it. Patients with a history of kidney disease, heart attack, stroke and coronary artery disease need to talk with their healthcare professional before taking Duraclon. The medication may result in adverse interactions if the affected role is also taking beta blockers, sleeping pills, and a number of supplements, vitamins and herbal medicines.
Duraclon is an a-adrenergic receptor agonist and has more affinity for a2 compared to a1. Receptors in the brain are selectively stimulated by the medication. These receptors are responsible for monitoring catecholamine levels in the blood. This stimulation causes the receptors to think that levels of catecholamine are higher than they are. The result is a reduction of catecholamine production and blood levels through relaxation and widening of blood vessels.
A survey of 35 children with FXS who were treated with Duraclon showed significant improvement in sleep disturbances, motor tics and hyperactivity. 63% of parents reported overall improvement in their child's condition, 20% reported minor improvement, 11% reported their child's condition became worse while 6% reported no noticeable effect. There were a number of exacerbated symptoms as well, including anxiety and sleep disturbances.
Duraclon is a prescription medication and should only be purchased from legitimate and verified pharmacies and healthcare professionals' clinics. The tablets and patches are also available online but consumers should check the source and manufacturer first to ensure freshness and authenticity of the products.
Patients should watch out for symptoms of Duraclon overdose such as lethargy, lightheadedness, emesis and drowsiness. The dose should be taken as prescribed by your healthcare professional. The medication should not be stopped abruptly even if the affected role's condition becomes better. The medication may need to be taken for life by those affected roles suffering from chronic hypertension for maintenance. Store the medication at room temperature away from sunlight, heat and moisture.
Duraclon has the following structural formula:
Molecular formula of duraclon is C9H9Cl2N3
Chemical IUPAC Name is N-(2,6-dichlorophenyl)-4,5-dihydro-1H-imidazol-2-amine
Molecular weight is 230.093 g/mol
Duraclon available : 0.1mg tablets, 0.2mg tablets, 0.3mg tablets
©2007-2017 Medicalook.com All rights reserved